Search Results - "Ehrlich, Hartmut"

Refine Results
  1. 1

    The Anti-Hiv Candidate Abx464 Dampens Intestinal Inflammation by Triggering Il-22 Production in Activated Macrophages by Chebli, Karim, Papon, Laura, Paul, Conception, Garcel, Aude, Campos, Noëlie, Scherrer, Didier, J. Ehrlich, Hartmut, Hahne, Michael, Tazi, Jamal

    Published in Scientific reports (07-07-2017)
    “…The progression of human immunodeficiency virus (HIV) is associated with mucosal damage in the gastrointestinal (GI) tract. This damage enables bacterial…”
    Get full text
    Journal Article
  2. 2

    Demonstration of the Antitumor Activity of the iNKT Agonist ABX196, a Novel Enhancer of Cancer Immunotherapy, in Melanoma and Hepatocarcinoma Mouse Models by Scherrer, Didier, Barrett, Noel, Teyton, Luc, Pearce, Tillman, Nitcheu, Josianne, Pouletty, Philippe, Santo, Julien, Ehrlich, Hartmut J

    Published in Molecular cancer therapeutics (02-12-2022)
    “…Immune checkpoint blockers (ICB) provide a promising approach to antitumor immunotherapy through blockade of immunosuppressive pathways. The synthetic…”
    Get full text
    Journal Article
  3. 3
  4. 4

    Both anti-inflammatory and antiviral properties of novel drug candidate ABX464 are mediated by modulation of RNA splicing by Vautrin, Audrey, Manchon, Laurent, Garcel, Aude, Campos, Noëlie, Lapasset, Laure, Laaref, Abdelhamid Mahdi, Bruno, Roman, Gislard, Marie, Dubois, Emeric, Scherrer, Didier, Ehrlich, J Hartmut, Tazi, Jamal

    Published in Scientific reports (28-01-2019)
    “…ABX464 is a first-in-class, clinical-stage, small molecule for oral administration that has shown strong anti-inflammatory effects in the DSS-model for…”
    Get full text
    Journal Article
  5. 5
  6. 6
  7. 7

    close look at human IgG sialylation and subclass distribution after lectin fractionation by Stadlmann, Johannes, Weber, Alfred, Pabst, Martin, Anderle, Heinz, Kunert, Renate, Ehrlich, Hartmut J, Peter Schwarz, Hans, Altmann, Friedrich

    Published in Proteomics (Weinheim) (01-09-2009)
    “…Polyspecific human IgG preparations are indicated for the treatment of primary immunodeficiency disorders associated with defects in humoral immunity. In…”
    Get full text
    Journal Article
  8. 8
  9. 9
  10. 10
  11. 11
  12. 12
  13. 13
  14. 14
  15. 15

    Pharmacokinetics and tolerability of ABX464, a novel first-in-class compound to treat HIV infection, in healthy HIV-uninfected subjects by Scherrer, Didier, Rouzier, Regine, Noel Barrett, P, Steens, Jean-Marc, Gineste, Paul, Murphy, Robert L, Tazi, Jamal, Ehrlich, Hartmut J

    Published in Journal of antimicrobial chemotherapy (01-03-2017)
    “…An anti-HIV compound (ABX464) has been developed with a novel mechanism of activity in that it blocks viral gene expression in cells that are already infected…”
    Get full text
    Journal Article
  16. 16
  17. 17

    Randomized Trial of Food Effect on Pharmacokinetic Parameters of ABX464 Administered Orally to Healthy Male Subjects by Scherrer, Didier, Rouzier, Regine, Cardona, Marine, Barrett, P Noel, Steens, Jean-Marc, Gineste, Paul, Murphy, Robert L, Tazi, Jamal, Ehrlich, Hartmut J

    Published in Antimicrobial agents and chemotherapy (01-01-2017)
    “…ABX464 is an antiviral that provides a novel approach to the reduction and control of HIV infection. Investigation of food influence is important in the…”
    Get full text
    Journal Article
  18. 18

    The influence of carrier protein on the immunogenicity of simultaneously administered conjugate vaccines in infants by Pöllabauer, Eva Maria, Petermann, Robert, Ehrlich, Hartmut J

    Published in Vaccine (10-03-2009)
    “…Abstract Continuing additions of new vaccines to routine infant vaccination schedules have prompted concerns about potential interactions between vaccine…”
    Get full text
    Journal Article
  19. 19

    Vero cell culture-derived pandemic influenza vaccines: preclinical and clinical development by Barrett, P Noel, Portsmouth, Daniel, Ehrlich, Hartmut J

    Published in Expert review of vaccines (01-04-2013)
    “…Several subtypes of influenza A viruses with pandemic potential are endemic in bird populations throughout Asia, Africa and the Middle East, and evidence…”
    Get more information
    Journal Article
  20. 20

    A Vero Cell-Derived Whole-Virus H5N1 Vaccine Effectively Induces Neuraminidase-Inhibiting Antibodies by Fritz, Richard, Sabarth, Nicolas, Kiermayr, Stefan, Hohenadl, Christine, Howard, M. Keith, Ilk, Reinhard, Kistner, Otfried, Ehrlich, Hartmut J., Barrett, P. Noel, Kreil, Thomas R.

    Published in The Journal of infectious diseases (01-01-2012)
    “…A Vero cell-derived whole-virus H5N1 influenza vaccine has been shown to induce neutralizing antibodies directed against the hemagglutinin (HA) protein of…”
    Get full text
    Journal Article